2021
DOI: 10.1002/acr.24163
|View full text |Cite
|
Sign up to set email alerts
|

Outcomes Reported in Prospective Long‐Term Observational Studies and Registries of Patients With Rheumatoid Arthritis Worldwide: An Outcome Measures in Rheumatology Systematic Review

Abstract: Objective Prospective long‐term observational studies (LOS) in rheumatoid arthritis (RA) lack a core set of universally collected outcome measures, particularly patient‐centered outcomes, precluding accurate comparisons across studies. Our aim was to identify long‐term outcome measures collected and reported in these studies. Methods We conducted a systematic review of registries and LOS of patients with RA, searching in ClinicalTrials.gov, the Agency for Healthcare Research and Quality Registry of Patient Reg… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
3
0
1

Year Published

2021
2021
2025
2025

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 39 publications
1
3
0
1
Order By: Relevance
“…This lack of reporting for treatment history would also be a limitation for the other definitions that are based on multiple bDMARDs [ 2 , 4 ]. The findings fit well with a systematic review of outcome measures used in 88 RA registries and long-term observational studies where disease activity (mainly DAS28) and physical functioning (mainly HAQ) was consistently recorded in included studies whilst there was heterogeneity in the patient-centred outcomes for symptom burden and psychosocial ramifications [ 2 , 122 ]. This type of validation was not conducted with the original definition of Refractory Disease [ 3 ], nor to the same degree with the most recent definitions [ 2 ].…”
Section: Discussionsupporting
confidence: 81%
“…This lack of reporting for treatment history would also be a limitation for the other definitions that are based on multiple bDMARDs [ 2 , 4 ]. The findings fit well with a systematic review of outcome measures used in 88 RA registries and long-term observational studies where disease activity (mainly DAS28) and physical functioning (mainly HAQ) was consistently recorded in included studies whilst there was heterogeneity in the patient-centred outcomes for symptom burden and psychosocial ramifications [ 2 , 122 ]. This type of validation was not conducted with the original definition of Refractory Disease [ 3 ], nor to the same degree with the most recent definitions [ 2 ].…”
Section: Discussionsupporting
confidence: 81%
“…Disease activity measures such as the DAS28, the most widely used [43], are not quite adequate to determine flares in RA, and fluctuations in disease activity may lead to radiologic progression [7]. In this longitudinal study, we found a moderate correlation between DAS28ESR and FLARE-RA score, which indicates that data on flare can be missed when using only DAS28ESR.…”
Section: Discussionmentioning
confidence: 68%
“…Additionally, PROs like pain and physical function appear to be stronger predictors of remission than traditional prognostic factors such as autoantibodies or radiographic erosions (9,10). However, while pain, fatigue and physical function are now widely collected as PROs for RA, less attention is often given to mental health and psychosocial wellbeing (11). Research has shown that suboptimal mental health persists in many patients with RA, despite successful treatment (7,12).…”
Section: Significance and Innovationsmentioning
confidence: 99%
“…However, although pain, fatigue, and physical function are now widely collected as patient-reported outcomes for RA, less attention is often given to mental health and psychosocial wellbeing (11). Research has shown that suboptimal mental health persists in many patients with RA, despite successful treatment (7,12).…”
Section: Introductionmentioning
confidence: 99%